Medicines Co. up on earnings news

MDCO gained $2.07 (11%) to $21.22 on Wednesday on news that increased demand for anticoagulant Angiomax is helping reduce wholesaler inventories and should make sales of the drug consistent with end user demand. The first week of October 2005, MDCO saw its valuation fall by 27% after it said lower-than-expected Angiomax sales and restructured wholesaler agreements would put it into the red in 2005. ...